Baxter (BAX) is a publicly traded Healthcare sector company. As of November 9, 2026, BAX trades at $26.44 with a market cap of $13.34B and a P/E ratio of -11.38. BAX moved +2.50% today. Year to date, BAX is +32.26%; over the trailing twelve months it is +43.44%. Its 52-week range spans $15.73 to $34.92. Analyst consensus is neutral with an average price target of $25.00. Rallies surfaces BAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover BAX: 0 strong buy, 0 buy, 6 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $25.00.
| Metric | Value |
|---|---|
| Price | $26.44 |
| Market Cap | $13.34B |
| P/E Ratio | -11.38 |
| EPS | $-2.07 |
| Dividend Yield | 0.01% |
| 52-Week High | $34.92 |
| 52-Week Low | $15.73 |
| Volume | 14.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.47B |
| Net Income | $-1.06B |
| Gross Margin | 30.08% |
7 analysts cover BAX: 0 strong buy, 0 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $25.00.